Cargando…

Early Hemodynamic Changes following Surgical Ablation of the Right Greater Splanchnic Nerve for the Treatment of Heart Failure with Preserved Ejection Fraction

Background: Permanent ablation of the right greater splanchnic nerve (GSN) has previously been demonstrated to improve quality of life and functional outcomes, as well as reduce abnormally high intracardiac filling pressures, in patients with heart failure with preserved ejection fraction (HFpEF) at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gajewski, Piotr, Fudim, Marat, Kittipibul, Veraprapas, Engelman, Zoar J., Biegus, Jan, Zymliński, Robert, Ponikowski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878100/ https://www.ncbi.nlm.nih.gov/pubmed/35207336 http://dx.doi.org/10.3390/jcm11041063

Ejemplares similares

Tackling Inflammation in Heart Failure With Preserved Ejection Fraction: Resurrection of Vagus Nerve Stimulation?
por: Kittipibul, Veraprapas, et al.
Publicado: (2022)

Splanchnic Nerve Ablation for Volume Management in Heart Failure
por: Fudim, Marat, et al.
Publicado: (2022)

Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE‐HF trial roll‐in cohort
por: Fudim, Marat, et al.
Publicado: (2022)

Clinical determinants and prognostic significance of hypocapnia in acute heart failure
por: Garus, Mateusz, et al.
Publicado: (2022)

Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
por: Tkaczyszyn, Michał, et al.
Publicado: (2023)

Safety, Feasibility of Controllable Decrease of Vena Cava Pressure by Doraya Catheter in Heart Failure
por: Zymliński, Robert, et al.
Publicado: (2023)

Splanchnic Nerve Modulation Effects on Surrogate Measures of Venous Capacitance
por: Kittipibul, Veraprapas, et al.
Publicado: (2023)

Spot urine sodium in acute heart failure: differences in prognostic value on admission and discharge
por: Biegus, Jan, et al.
Publicado: (2021)

One Small Step for a Patient, One Giant Leap for Orthostatic Hypotension
por: Coniglio, Amanda C, et al.
Publicado: (2022)

Novel IVC Doraya Catheter Provides Congestion Relief in Patients With Acute Heart Failure
por: Zymliński, Robert, et al.
Publicado: (2022)

Novel Therapeutic Devices in Heart Failure
por: Guzik, Mateusz, et al.
Publicado: (2022)

Biomarkers of Myocardial Injury and Remodeling in Heart Failure
por: Ponikowska, Barbara, et al.
Publicado: (2022)

Novel Biomarkers of Renal Dysfunction and Congestion in Heart Failure
por: Zdanowicz, Agata, et al.
Publicado: (2022)

Prognostic significance and clinical determinants of residual dyspnoea at discharge in acute heart failure: a single-centre, prospective observational study
por: Garus, Mateusz, et al.
Publicado: (2023)

Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure
por: Nawrocka-Millward, Sylwia, et al.
Publicado: (2021)

Distinct clinical phenotypes of congestion in acute heart failure: characteristics, treatment response, and outcomes
por: Sokolska, Justyna Maria, et al.
Publicado: (2020)

Sympathetic and hemodynamic responses to exercise in heart failure with preserved ejection fraction
por: Manabe, Kazumasa, et al.
Publicado: (2023)

Elevated plasma endothelin‐1 is related to low natriuresis, clinical signs of congestion, and poor outcome in acute heart failure
por: Zymliński, Robert, et al.
Publicado: (2020)

Comparison of left ventricular longitudinal systolic function parameters in the prediction of adverse outcome in heart failure with preserved ejection fraction
por: Gozdzik, Anna, et al.
Publicado: (2021)

Inhibition of peripheral chemoreceptors improves ventilatory efficiency during exercise in heart failure with preserved ejection fraction − a role of tonic activity and acute reflex response
por: Kulej-Lyko, Katarzyna, et al.
Publicado: (2022)

Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
por: Salah, Husam M., et al.
Publicado: (2021)

Hemodynamic Profile of Patients With Heart Failure and Preserved Ejection Fraction Vary by Age
por: Nanayakkara, Shane, et al.
Publicado: (2017)

Novel Phenotyping for Acute Heart Failure—Unsupervised Machine Learning-Based Approach
por: Urban, Szymon, et al.
Publicado: (2022)

Neural control of inflammation by the greater splanchnic nerves
por: Martelli, Davide, et al.
Publicado: (2014)

Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM‐HFpEF)
por: Linde, Cecilia, et al.
Publicado: (2022)

Renal Assessment in Acute Cardiorenal Syndrome
por: Łagosz, Piotr, et al.
Publicado: (2023)

Serum Osmolarity and Vasopressin Concentration in Acute Heart Failure—Influence on Clinical Course and Outcome
por: Guzik, Mateusz, et al.
Publicado: (2022)

Morphometric, Hemodynamic, and Multi-Omics Analyses in Heart Failure Rats with Preserved Ejection Fraction
por: Zhang, Wenxi, et al.
Publicado: (2020)

COVID-19 Related Myocarditis in Adults: A Systematic Review of Case Reports
por: Urban, Szymon, et al.
Publicado: (2022)

Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction
por: Butler, Javed, et al.
Publicado: (2022)

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
por: Branca, Luca, et al.
Publicado: (2020)

Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: Rosalia, Luca, et al.
Publicado: (2021)

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
por: Butler, Javed, et al.
Publicado: (2021)

Diabetes Associated With Greater Ejection Fraction Improvement After Revascularization in Patients With Reduced Ejection Fraction
por: Wang, Shaoping, et al.
Publicado: (2021)

Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis
por: Fudim, Marat, et al.
Publicado: (2020)

Elevated intra-abdominal pressure: A review of current knowledge
por: Łagosz, Piotr, et al.
Publicado: (2022)

Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT
por: Peters, Anthony E., et al.
Publicado: (2021)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Impaired Myocardial Oxygen Availability Contributes to Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: van Empel, Vanessa P. M., et al.
Publicado: (2014)

Hemodynamic Evaluation of a Centrifugal Left Atrial Decompression Pump for Heart Failure with Preserved Ejection Fraction
por: Abbasnezhad, Navideh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lac1ne74860aebpkfc86a18k6h